Skip to main content
Livermore
Livermore
ZHEN

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
399,847
Value
$249.3M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026399,847$249.3M0.1%−48,524−10.8%ReducedHolders
Q1 2026448,371$346.4M0.2%+7,527+1.7%AddedHolders
Q4 2025440,844$340.3M0.2%−36,808−7.7%ReducedHolders
Q3 2025477,652$268.6M0.2%−46,706−8.9%ReducedHolders
Q2 2025524,358$275.3M0.2%−222,255−29.8%ReducedHolders
Q1 2025746,613$473.5M0.4%+207,017+38.4%AddedHolders
Q4 2024539,596$384.4M0.3%+244,184+82.7%AddedHolders
Q3 2024295,412$310.5M0.3%+48,721+19.7%AddedHolders
Q2 2024246,691$259.3M0.3%+6,867+2.9%AddedHolders
Q1 2024239,824$230.8M0.3%+24,286+11.3%AddedHolders
Q4 2023215,538$189.3M0.3%+30,432+16.4%AddedHolders
Q3 2023185,106$152.3M0.3%+33,903+22.4%AddedHolders
Q2 2023151,203$108.6M0.2%+41,165+37.4%AddedHolders
Q1 2023110,038$90.4M0.2%+9,640+9.6%AddedHolders
Q4 2022100,398$72.4M0.2%+15,401+18.1%AddedHolders
Q3 202284,997$58.6M0.1%−7,260−7.9%ReducedHolders
Q2 202292,257$54.5M0.1%+25,417+38.0%AddedHolders
Q1 202266,840$46.7M0.1%−16,543−19.8%ReducedHolders
Q4 202183,383$52.7M0.1%+34,116+69.2%AddedHolders
Q3 202149,267$29.8M0.1%−31,315−38.9%ReducedHolders
Q2 202180,582$45.0M0.1%+6,611+8.9%AddedHolders
Q1 202173,971$35.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.